{"id":46981,"date":"2026-02-19T13:30:41","date_gmt":"2026-02-19T13:30:41","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/breast-cancer-therapeutics-market-mordor\/"},"modified":"2026-09-25T11:52:59","modified_gmt":"2026-09-25T02:52:59","slug":"breast-cancer-therapeutics-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/breast-cancer-therapeutics-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026\ub144~2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/breast-cancer-therapeutics-market_1612534087652_Breast_Cancer_Therapy_Market_Logo.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/breast-cancer-therapeutics-market-size-image-1770808579567.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc720\ubc29\uc554\uc758 \ub192\uc740 \ubc1c\uc0dd\ub960 \ubc0f \uc720\ubcd1\ub960<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc99d\uac00\ud558\ub294 R&amp;D \uc9c0\ucd9c \ubc0f \uc885\uc591\ud559 \uac70\ub798 \uc131\uc0ac<\/li>\n<li class=\"toc-level-3\">4.2.3 HER2 \/ CDK4-6 \ud45c\uc801 \uce58\ub8cc\uc81c\uc758 \ube60\ub978 \ucc44\ud0dd<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc2e0\ud765 \uacbd\uc81c\uad6d\uc5d0\uc11c\uc758 \uc2a4\ud06c\ub9ac\ub2dd \uc811\uadfc\uc131 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.5 AI \uae30\ubc18 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc1c\uacac\uc744 \ud1b5\ud55c \ud30c\uc774\ud504\ub77c\uc778 \uac00\uc18d\ud654<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ubd80\uc791\uc6a9 \ubc0f \ub3c5\uc131 \uad00\ub9ac \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc5c4\uaca9\ud55c \ub2e4\uc9c0\uc5ed \uaddc\uc81c \uc77c\uc815<\/li>\n<li class=\"toc-level-3\">4.3.3 \uace0\ud6a8\ub2a5 ADC \ud398\uc774\ub85c\ub4dc \uc81c\uc870\uc758 \ud76c\uc18c\uc131<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778\n<ul>\n<li class=\"toc-level-3\">4.5.1 \uacf5\uae09\uc5c5\uccb4\uc758 \ud611\uc0c1\ub825<\/li>\n<li class=\"toc-level-3\">4.5.2 \uad6c\ub9e4\uc790\uc758 \ud611\uc0c1\ub825<\/li>\n<li class=\"toc-level-3\">4.5.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uce58\ub8cc\ubc95\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \ubc29\uc0ac\uc120 \uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.1.2 \ud638\ub974\ubaac \uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.1.3 \ud654\ud559 \uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.1.4 \ud45c\uc801 \uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.1.5 \uba74\uc5ed \uc694\ubc95<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \ubd84\uc790 \uc544\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 HR+ \/ HER2-<\/li>\n<li class=\"toc-level-3\">5.2.2 HER2+<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc0bc\uc911 \uc74c\uc131 (TNBC)<\/li>\n<li class=\"toc-level-3\">5.2.4 \uc0ac\uc911 \uc74c\uc131 (QNBC)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc9c8\ubcd1 \ub2e8\uacc4\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ucd08\uae30 \/ \ubcf4\uc870<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc804\uc774\uc131 \/ \uc9c4\ud589\uc131<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ud22c\uc5ec \uacbd\ub85c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uc815\ub9e5 \uc8fc\uc0ac<\/li>\n<li class=\"toc-level-3\">5.4.2 \ud53c\ud558 \uc8fc\uc0ac<\/li>\n<li class=\"toc-level-3\">5.4.3 \uacbd\uad6c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc720\ud1b5 \ucc44\ub110\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubcd1\uc6d0 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc18c\ub9e4 &amp; \uc804\ubb38 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc804\uc790\uc0c1\uac70\ub798<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uc9c0\uc5ed\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.6.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.6.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.6.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.6.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.6.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.6.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.6.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.6.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.6.3.4 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.5 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.6.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.6.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.6.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.6.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.6.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.6.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \uc0ac\uc5c5 \ubd80\ubb38, \uc7ac\ubb34, \uc778\ub825, \uc8fc\uc694 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704, \uc2dc\uc7a5 \uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ubd84\uc11d \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Roche Holding AG<\/li>\n<li class=\"toc-level-3\">6.3.2 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.3 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.4 AstraZeneca PLC<\/li>\n<li class=\"toc-level-3\">6.3.5 Eli Lilly and Company<\/li>\n<li class=\"toc-level-3\">6.3.6 Bristol-Myers Squibb<\/li>\n<li class=\"toc-level-3\">6.3.7 Merck &amp; Co.<\/li>\n<li class=\"toc-level-3\">6.3.8 Johnson &amp; Johnson (Janssen)<\/li>\n<li class=\"toc-level-3\">6.3.9 GSK plc<\/li>\n<li class=\"toc-level-3\">6.3.10 Eisai Co. Ltd<\/li>\n<li class=\"toc-level-3\">6.3.11 Teva Pharmaceutical<\/li>\n<li class=\"toc-level-3\">6.3.12 Fresenius Kabi<\/li>\n<li class=\"toc-level-3\">6.3.13 Baxter International<\/li>\n<li class=\"toc-level-3\">6.3.14 Hikma Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.3.15 Celltrion Healthcare<\/li>\n<li class=\"toc-level-3\">6.3.16 Viatris Inc.<\/li>\n<li class=\"toc-level-3\">6.3.17 AbbVie Inc.<\/li>\n<li class=\"toc-level-3\">6.3.18 Amgen Inc.<\/li>\n<li class=\"toc-level-3\">6.3.19 Sanofi S.A.<\/li>\n<li class=\"toc-level-3\">6.3.20 Bayer AG<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \ub3d9\ud5a5 \ubd84\uc11d (2026-2031)<\/p>\n<p># 1. \uc2dc\uc7a5 \uac1c\uc694<\/p>\n<p>\uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 2025\ub144 329\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 352\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \ucd94\uc815\ub418\uba70, 2031\ub144\uc5d0\ub294 495\uc5b5 9\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub3c4\ub2ec\ud558\uc5ec 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 7.08%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uc720\ubc29\uc554 \ubc1c\ubcd1\ub960\uc758 \uafb8\uc900\ud55c \uc99d\uac00, \uaddc\uc81c \uc2b9\uc778 \uac00\uc18d\ud654, \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADC)\uc758 \ube60\ub978 \ucc44\ud0dd\uc5d0 \ud798\uc785\uc740 \ubc14\uac00 \ud07d\ub2c8\ub2e4. \ubc14\uc774\uc624\ub9c8\ucee4 \uae30\ubc18 \uce58\ub8cc\ubc95\uc758 \ud65c\uc6a9 \uc99d\uac00, CDK4\/6 \uc5b5\uc81c\uc81c\uc758 \uc870\uae30 \ub3c4\uc785, \uace0\uac00 \ud45c\uc801 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \uc9c0\ubd88\uc790\uc758 \uc218\uc6a9 \ud655\ub300\uac00 \uc2dc\uc7a5 \ub9e4\ucd9c \uae30\ubc18\uc744 \ub113\ud788\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uba74\uc5ed \uce58\ub8cc\uc81c \ubcd1\uc6a9 \uc694\ubc95\uc740 \uce58\ub8cc \uc54c\uace0\ub9ac\uc998\uc744 \ud655\uc7a5\ud558\uace0 \uc788\uc73c\uba70, \ud53c\ud558 \uc8fc\uc0ac \uc81c\ud615 \ubc0f \uc804\uc790\uc0c1\uac70\ub798 \ucc44\ub110\uc740 \uce58\ub8cc \uc804\ub2ec \ubc29\uc2dd\uc744 \ubcc0\ud654\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uace0\ud6a8\ub2a5 \ud398\uc774\ub85c\ub4dc\uc758 \uc81c\uc870 \uc5ed\ub7c9 \uc81c\ud55c\uacfc \ubcf5\uc7a1\ud55c \ub2e4\uc9c0\uc5ed \uc2b9\uc778 \uc808\ucc28\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0, \uc0c1\ub2f9\ud55c R&#038;D \ud22c\uc790\uc640 AI \uae30\ubc18 \uc2e0\uc57d \ubc1c\uad74 \ud30c\uc774\ud504\ub77c\uc778\uc740 \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uc7a5\uae30\uc801\uc778 \uc804\ub9dd\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc9c0\ud45c:<br \/>\n*   \uc5f0\uad6c \uae30\uac04: 2020\ub144 &#8211; 2031\ub144<br \/>\n*   2026\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 352\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   2031\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 495\uc5b5 9\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   \uc131\uc7a5\ub960 (2026-2031): 7.08% CAGR<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5: \ubd81\ubbf8<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \uc911\uac04<\/p>\n<p>\uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d (2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubc0f 2031\ub144 CAGR):<br \/>\n*   \uce58\ub8cc\ubc95\ubcc4: \ud45c\uc801 \uce58\ub8cc\uc81c\uac00 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 62.45%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uba74\uc5ed \uce58\ub8cc\uc81c\ub294 2031\ub144\uae4c\uc9c0 13.95%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ubd84\uc790 \uc544\ud615\ubcc4: HR+\/HER2- \uc9c8\ud658\uc774 2025\ub144 \ub9e4\ucd9c\uc758 64.78%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc0bc\uc911 \uc74c\uc131 \uc720\ubc29\uc554(TNBC)\uc740 2031\ub144\uae4c\uc9c0 12.08%\uc758 CAGR\ub85c \ud655\uc7a5\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c8\ubcd1 \ub2e8\uacc4\ubcc4: \uc804\uc774\uc131\/\uc9c4\ud589\uc131 \uc9c8\ud658\uc774 2025\ub144 \ub9e4\ucd9c\uc758 54.15%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \ucd08\uae30\/\ubcf4\uc870 \uc694\ubc95\uc740 10.44%\uc758 CAGR\ub85c \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud22c\uc5ec \uacbd\ub85c\ubcc4: \ud53c\ud558 \uc8fc\uc0ac \uc81c\ud615\uc740 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 11.35%\uc758 CAGR\ub85c \ubc1c\uc804\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8\uac00 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 38.05%\ub85c \uc120\ub450\ub97c \ub2ec\ub838\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2031\ub144\uae4c\uc9c0 11.85%\uc758 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<\/p>\n<p># 2. \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30<\/p>\n<p> 2.1. \uc131\uc7a5 \ub3d9\ub825 (Drivers)<\/p>\n<p>*   \uc720\ubc29\uc554 \ubc1c\ubcd1\ub960 \ubc0f \uc720\ubcd1\ub960 \uc99d\uac00: \uc720\ubc29\uc554\uc740 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uac00\uc7a5 \ud754\ud558\uac8c \uc9c4\ub2e8\ub418\ub294 \uc545\uc131 \uc885\uc591\uc73c\ub85c, \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \uc9c0\uc18d\uc801\uc778 \uc218\uc694\ub97c \uacac\uc778\ud569\ub2c8\ub2e4. \uc778\uad6c \uace0\ub839\ud654\uc640 \uc0dd\ud65c \uc2b5\uad00 \ubcc0\ud654\ub294 \ubc1c\ubcd1\ub960\uc744 \uac00\uc18d\ud654\ud558\uba70, \ud2b9\ud788 \ub3c4\uc2dc\ud654 \ucd94\uc138\uac00 \ub69c\ub837\ud55c \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc2dc\uc7a5\uc5d0\uc11c \ub450\ub4dc\ub7ec\uc9d1\ub2c8\ub2e4. MENA(\uc911\ub3d9 \ubc0f \ubd81\uc544\ud504\ub9ac\uce74) \uc9c0\uc5ed\uc740 2040\ub144\uae4c\uc9c0 \uc554 \ubc1c\uc0dd\ub960\uc774 50% \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc720\ubc29\uc554\uc774 \uadf8 \uc99d\uac00\ub97c \uc8fc\ub3c4\ud560 \uac83\uc785\ub2c8\ub2e4. \uc870\uae30 \ubc1c\uacac \ubc0f \uc0dd\uc874\uc728 \uac1c\uc120\uc740 \uc720\ubcd1 \ud658\uc790 \uc218\ub97c \uc99d\uac00\uc2dc\ucf1c, \uc758\ub8cc \uc2dc\uc2a4\ud15c\uc774 \ubc18\uc751\uc801 \ubaa8\ub378\uc5d0\uc11c \uc0ac\uc804 \uc608\ubc29\uc801 \ubaa8\ub378\ub85c \uc804\ud658\ud568\uc5d0 \ub530\ub77c \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc744 \ubcf4\uc7a5\ud569\ub2c8\ub2e4.<br \/>\n*   R&#038;D \ud22c\uc790 \ubc0f \uc885\uc591\ud559 \ubd84\uc57c M&#038;A \uc99d\uac00: \uae30\ub85d\uc801\uc778 \uc885\uc591\ud559 \ubd84\uc57c \ud22c\uc790\ub294 \uc784\uc0c1 \uc2dc\ud5d8 \uac00\uc18d\ud654\uc640 \ucc28\ubcc4\ud654\ub41c \uba54\ucee4\ub2c8\uc998\uc5d0 \ub300\ud55c \ud504\ub9ac\ubbf8\uc5c4 \uac00\uce58 \ud3c9\uac00\ub97c \ucd09\uc9c4\ud569\ub2c8\ub2e4. \uc0ac\ub178\ud53c(Sanofi)\uc758 \uc624\ub77c\ub178 \uba54\ub4dc(Orano Med) \uc778\uc218\uc640 \uc77c\ub77c\uc774 \ub9b4\ub9ac(Eli Lilly)\uc758 \ub77c\ub514\uc624\ub124\ud2f1\uc2a4(Radionetics) \uc778\uc218\ub294 \ucc28\uc138\ub300 \ubc29\uc0ac\uc131 \ub9ac\uac04\ub4dc(radioligand) \uc5ed\ub7c9 \ud655\ubcf4\ub97c \ubaa9\ud45c\ub85c \ud55c \ub300\ud45c\uc801\uc778 \uc0ac\ub840\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uac70\ub798\ub294 \uc18c\uaddc\ubaa8 \ubc14\uc774\uc624\ud14d\uc758 \uac1c\ubc1c \uae30\uac04\uc744 \ub2e8\ucd95\ud558\uace0, \uc131\uacf5\uc801\uc778 \uc2e0\uc57d \ucd9c\uc2dc\uac00 \ucd94\uac00 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5\uc744 \uc704\ud55c \uc790\uae08\uc73c\ub85c \uc774\uc5b4\uc9c0\ub294 \uc120\uc21c\ud658\uc744 \ub9cc\ub4e4\uc5b4 \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc744 \ud65c\uc131\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   HER2\/CDK4-6 \ud45c\uc801 \uce58\ub8cc\uc81c\uc758 \ube60\ub978 \ucc44\ud0dd: \ud2b8\ub77c\uc2a4\ud22c\uc8fc\ub9d9 \ub370\ub8e9\uc2a4\ud14c\uce78(Trastuzumab deruxtecan)\uc774 HER2-low \uc9c8\ud658\uc73c\ub85c \uc801\uc751\uc99d\uc744 \ud655\uc7a5\ud558\uba74\uc11c \uce58\ub8cc \ub300\uc0c1 \uc778\uad6c\uac00 \ud6a8\uacfc\uc801\uc73c\ub85c \ub450 \ubc30 \uc99d\uac00\ud588\uc2b5\ub2c8\ub2e4. NATALEE \uc5f0\uad6c \uc774\ud6c4 \ub9ac\ubcf4\uc2dc\ud074\ub9bd(Ribociclib)\uc758 \ubcf4\uc870 \uc694\ubc95 \uc2b9\uc778\uc740 \ucd08\uae30 \ub2e8\uacc4 \ud65c\uc6a9\uc744 \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4. \uc0c1\ub2f9\ud55c \uc0dd\uc874\uc728 \uac1c\uc120\uc740 \ud504\ub9ac\ubbf8\uc5c4 \uac00\uaca9\uc744 \uc815\ub2f9\ud654\ud558\uba70, \ub2e4\uc591\ud55c \uce58\ub8cc \ud658\uacbd\uc5d0\uc11c \ucc44\ud0dd\uc744 \uac00\uc18d\ud654\ud558\uc5ec \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud569\ub2c8\ub2e4.<br \/>\n*   \uc2e0\ud765 \uacbd\uc81c\uad6d\uc758 \uac80\uc9c4 \uc811\uadfc\uc131 \ud655\ub300: \uc778\ub3c4\uc640 \uc911\uad6d \uc815\ubd80\uc758 \ud504\ub85c\uadf8\ub7a8\uc740 \uc720\ubc29 \ucd2c\uc601\uc220(mammography) \uac00\uc6a9\uc131\uc744 \ud655\ub300\ud558\uc5ec \uc9c4\ub2e8\uc744 \ucd08\uae30 \ub2e8\uacc4\ub85c \uc804\ud658\ud558\uace0 \ubcf4\uc870 \uc694\ubc95\uc5d0 \ub300\ud55c \uc218\uc694\ub97c \uc790\uadf9\ud569\ub2c8\ub2e4. CLAIRITY BREAST\uc640 \uac19\uc740 AI \uae30\ubc18 \ub3c4\uad6c\ub294 \uc77c\uc0c1\uc801\uc778 \uc9c4\ub8cc\uc5d0\uc11c \uc704\ud5d8 \uc608\uce21\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4. \uc870\uae30 \ubc1c\uacac\uc740 \uce58\ub8cc \uae30\uac04\uc744 \uc5f0\uc7a5\ud558\uc5ec \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \ub9e4\ucd9c \ud750\ub984\uc744 \uac15\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc1c\uad74\uc744 \ud1b5\ud55c \ud30c\uc774\ud504\ub77c\uc778 \uac00\uc18d\ud654: AI \uae30\uc220\uc740 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc1c\uad74 \ubc0f \uc2e0\uc57d \uac1c\ubc1c \ud30c\uc774\ud504\ub77c\uc778\uc744 \uac00\uc18d\ud654\ud558\uc5ec \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae0d\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\uce69\ub2c8\ub2e4.<\/p>\n<p> 2.2. \uc131\uc7a5 \uc800\ud574 \uc694\uc778 (Restraints)<\/p>\n<p>*   \ubd80\uc791\uc6a9 \ubc0f \ub3c5\uc131 \uad00\ub9ac \ube44\uc6a9: ADC\uc640 \uac19\uc740 \ubcf5\ud569 \uc694\ubc95\uc740 \uc9d1\uc911\uc801\uc778 \ubaa8\ub2c8\ud130\ub9c1\uacfc \ubcf4\uc870 \uce58\ub8cc\ub97c \ud544\uc694\ub85c \ud558\uba70, \uc774\ub294 \ub54c\ub54c\ub85c \uc804\uccb4 \uce58\ub8cc \ube44\uc6a9\uc744 \ub450 \ubc30\ub85c \uc99d\uac00\uc2dc\ud0ac \uc218 \uc788\uc2b5\ub2c8\ub2e4. FDA\uc758 Project Optimus\ub294 \uc6a9\ub7c9 \ucd5c\uc801\ud654\uc758 \ud544\uc694\uc131\uc744 \uac15\uc870\ud569\ub2c8\ub2e4. \uc800\uc18c\ub4dd \uad6d\uac00\uc758 \uc81c\ud55c\ub41c \ubcf4\uc870 \uc778\ud504\ub77c\ub294 \uce58\ub8cc\uc81c \ucc44\ud0dd\uc744 \uc800\ud574\ud558\uc5ec \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc744 \uc81c\uc57d\ud569\ub2c8\ub2e4.<br \/>\n*   \uc5c4\uaca9\ud55c \ub2e4\uc9c0\uc5ed \uaddc\uc81c \uc2b9\uc778 \uc808\ucc28: \ubaa8\ub85c\ucf54 \uc0ac\ub840\uc5d0\uc11c \ubcfc \uc218 \uc788\ub4ef\uc774, \ucd5c\ucd08 \uc2b9\uc778\uacfc \uc2e0\ud765 \uc2dc\uc7a5 \uc811\uadfc \uc0ac\uc774\uc5d0 3-4\ub144\uc758 \uc2b9\uc778 \uc9c0\uc5f0\uc774 \uc9c0\uc18d\ub429\ub2c8\ub2e4. \uad6d\uac00\ubcc4\ub85c \uc0c1\uc774\ud55c \ud45c\uc900\uc740 \ube44\uc6a9\uc744 \uc99d\uac00\uc2dc\ud0a4\uace0 \ub9e4\ucd9c \uc778\uc2dd\uc744 \uc9c0\uc5f0\uc2dc\ucf1c \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uc131\uc7a5 \uc7a0\uc7ac\ub825\uc744 \uc81c\ud55c\ud569\ub2c8\ub2e4.<br \/>\n*   \uace0\ud6a8\ub2a5 ADC \ud398\uc774\ub85c\ub4dc \uc81c\uc870\uc758 \ud76c\uc18c\uc131: \uace0\ud6a8\ub2a5 ADC \ud398\uc774\ub85c\ub4dc \uc81c\uc870\uc758 \ud76c\uc18c\uc131\uc740 \uacf5\uae09 \uc81c\uc57d\uc73c\ub85c \uc774\uc5b4\uc838 \uc804 \uc138\uacc4 \ubaa8\ub4e0 \uc9c0\uc5ed\uc5d0 \uc601\ud5a5\uc744 \ubbf8\uce58\uba70, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p># 3. \uc138\uadf8\uba3c\ud2b8\ubcc4 \ubd84\uc11d<\/p>\n<p> 3.1. \uce58\ub8cc\ubc95\ubcc4 (By Therapy)<\/p>\n<p>\ud45c\uc801 \uce58\ub8cc\uc81c\ub294 2025\ub144 \ub9e4\ucd9c\uc758 62.45%\ub97c \ucc28\uc9c0\ud558\uba70 \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0\uc11c \ud575\uc2ec\uc801\uc778 \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4. \ud2b8\ub77c\uc2a4\ud22c\uc8fc\ub9d9 \ub370\ub8e9\uc2a4\ud14c\uce78\uc758 HER2-low \uc9c8\ud658 \ud655\uc7a5\uacfc PIK3CA \ubcc0\uc774 \uc885\uc591\uc5d0\uc11c\uc758 \uc774\ub098\ubcfc\ub9ac\uc2ed(inavolisib) \ud65c\uc131\uc740 \uce58\ub8cc \ub300\uc0c1 \ud658\uc790\uad70\uc744 \ud655\ub300\ud569\ub2c8\ub2e4. \uba74\uc5ed \uce58\ub8cc\uc81c\ub294 13.95%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc138\uadf8\uba3c\ud2b8\ub85c, \uc0bc\uc911 \uc74c\uc131 \uc720\ubc29\uc554\uc5d0\uc11c \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc5b5\uc81c\uc81c-ADC \ubcd1\uc6a9 \uc694\ubc95\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub429\ub2c8\ub2e4. \ud638\ub974\ubaac \uc694\ubc95\uc740 HR-\uc591\uc131 \ud658\uc790\uad70\uc5d0\uc11c \uc5ec\uc804\ud788 \uc911\uc694\ud558\uba70, \uc0c8\ub85c\uc6b4 \uce58\ub8cc\ubc95\uc73c\ub85c \ub0b4\uc57d\uc131\uc774 \uac1c\uc120\ub428\uc5d0 \ub530\ub77c \ud654\ud559 \uc694\ubc95\uc758 \ube44\uc911\uc740 \uac10\uc18c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubc29\uc0ac\uc120 \uc694\ubc95\uc740 \uc785\uccb4\uc815\uc704 \uccb4\ubd80 \ubc29\uc0ac\uc120(SBRT) \uae30\uc220\uacfc \uac19\uc740 \ubc1c\uc804\uc73c\ub85c \ub178\ucd9c\uc744 \ucd5c\uc18c\ud654\ud558\uace0 \ubc29\ubb38 \ud69f\uc218\ub97c \uc904\uc5ec \ubcf4\uc870 \uc694\ubc95 \ud658\uacbd\uc5d0\uc11c \ucc44\ud0dd\uc774 \uc9c0\uc18d\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub2e4\uc591\ud55c \uce58\ub8cc\ubc95\uc744 \ud63c\ud569\ud55c \ubcd1\uc6a9 \uc694\ubc95\uc740 \uc9c4\ub8cc \ud328\ud134\uc744 \ubcc0\ud654\uc2dc\ud0a4\uace0 \ub3d9\ubc18 \uc9c4\ub2e8\ubc95 \uac1c\ubc1c\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud45c\uc801 \uce58\ub8cc\uc81c\ub294 \uc810\ucc28 \ucd08\uae30 \uce58\ub8cc \ub77c\uc778\uc73c\ub85c \uc774\ub3d9\ud558\uace0 \uc788\uc73c\uba70, \uc6b0\uc218\ud55c \uc704\ud5d8-\uc774\uc810 \ud504\ub85c\ud30c\uc77c\uc740 \uac00\uaca9\uc5d0 \ubbfc\uac10\ud55c \uc2dc\uc2a4\ud15c\uc5d0\uc11c\ub3c4 \uc9c0\uc18d\uc801\uc778 \ubcf4\ud5d8 \uc801\uc6a9\uc744 \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4. \uac1c\ubc1c\uc790\ub4e4\uc740 AI\ub97c \ud65c\uc6a9\ud558\uc5ec \ud658\uc790 \uc120\ud0dd\uc744 \uc815\uad50\ud654\ud558\uace0 \ud6a8\ub2a5 \uc2e0\ud638\ub97c \ub354\uc6b1 \uac1c\uc120\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud45c\uc801 \uce58\ub8cc\ubc95\uc758 \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8\ub294 \uacac\uace0\ud55c \ud30c\uc774\ud504\ub77c\uc778\uacfc \uc9c0\uc18d\uc801\uc778 \ud22c\uc790\ub97c \ubc18\uc601\ud558\uc5ec \uafb8\uc900\ud788 \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p> 3.2. \ubd84\uc790 \uc544\ud615\ubcc4 (By Molecular Subtype)<\/p>\n<p>HR+\/HER2- \uc9c8\ud658\uc740 2025\ub144 \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uc9c0\ucd9c\uc758 64.78%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7fc\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \uc0bc\uc911 \uc74c\uc131 \uc720\ubc29\uc554(TNBC)\uc740 \uc0ac\uc2dc\ud22c\uc8fc\ub9d9 \uace0\ube44\ud14c\uce78(sacituzumab govitecan) \ubc0f \ud6c4\uc18d TROP2 ADC\uc5d0 \ud798\uc785\uc5b4 12.08%\uc758 CAGR\ub85c \ud655\uc7a5\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. HER2 \uc591\uc131 \uc9c8\ud658\uc740 \ud2b8\ub77c\uc2a4\ud22c\uc8fc\ub9d9 \ub370\ub8e9\uc2a4\ud14c\uce78\uc774 \ucd08\uc800\ubc1c\ud604(ultralow expression) \ud658\uc790\uad70\uc73c\ub85c \ud655\uc7a5\ub428\uc5d0 \ub530\ub77c \ubaa8\uba58\ud140\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubd84\uc790 \ud504\ub85c\ud30c\uc77c\ub9c1\uc744 \ud1b5\ud55c \uc0ac\uc911 \uc74c\uc131(quadruple-negative) \ud558\uc704 \uadf8\ub8f9\uc758 \uad6c\ubd84\uc740 \uc9c8\ubcd1\uc744 \ub354\uc6b1 \uc138\ubd84\ud654\ud569\ub2c8\ub2e4. \uc784\uc0c1 \ub370\uc774\ud130\ub294 TNBC\uc5d0 \ub300\ud55c \uc778\uc2dd\uc744 \ud76c\uadc0 \uc544\ud615\uc5d0\uc11c \uace0\uac00\uce58 \uae30\ud68c\ub85c \uc804\ud658\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \uc131\uacf5\uc740 \ud56d\uccb4 \uacf5\ud559, \uc774\uc911 \ud2b9\uc774\uc131 \uad6c\uc870 \ubc0f \uc0c8\ub85c\uc6b4 \ud398\uc774\ub85c\ub4dc\uc5d0 \ub300\ud55c \ucd94\uac00 \ud22c\uc790\ub85c \uc774\uc5b4\uc9d1\ub2c8\ub2e4. \ubc14\uc774\uc624\ub9c8\ucee4 \uac80\uc0ac\uac00 \uc77c\uc0c1\ud654\ub428\uc5d0 \ub530\ub77c \uac1c\ubc1c\uc790\ub4e4\uc740 \uc784\uc0c1 \uc2dc\ud5d8 \uc124\uacc4\ub97c \uc870\uc815\ud558\uc5ec \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \ub0b4 TNBC \uce58\ub8cc\uc81c\uc758 \uc9c0\uc18d\uc801\uc778 \uc810\uc720\uc728 \uc99d\uac00\ub97c \uc9c0\uc6d0\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p> 3.3. \uc9c8\ubcd1 \ub2e8\uacc4\ubcc4 (By Disease Stage)<\/p>\n<p>\uc804\uc774\uc131 \uc9c8\ud658\uc740 2025\ub144 \ub9e4\ucd9c\uc758 54.15%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ucd08\uae30\/\ubcf4\uc870 \uc694\ubc95\uc740 \ub9ac\ubcf4\uc2dc\ud074\ub9bd \ubc0f \uae30\ud0c0 \uc57d\ubb3c\ub4e4\uc774 \uc7ac\ubc1c \uc804 \ud6a8\ub2a5\uc744 \uc785\uc99d\ud568\uc5d0 \ub530\ub77c 10.44%\uc758 CAGR\ub85c \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubc14\uc774\uc624\ub9c8\ucee4 \uae30\ubc18 \uc2e0\ubcf4\uc870 \uc694\ubc95\uc740 \ubcd1\ub9ac\ud559\uc801 \uc644\uc804 \uad00\ud574\uc728\uc744 \ub192\uc5ec \uaddc\uc81c \ud3c9\uac00 \uae30\uc900\uc5d0 \uc601\ud5a5\uc744 \ubbf8\uce69\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc9c8\ubcd1 \ub2e8\uacc4 \uc774\ub3d9 \ucd94\uc138\ub294 \ud658\uc790 \uc5ec\uc815\uc758 \ucd08\uae30 \uc2dc\uc810\uc5d0\uc11c \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8\ub97c \ud655\uc7a5\ud569\ub2c8\ub2e4. \uc120\ud589 \uce58\ub8cc\ub294 \ub098\uc911\uc5d0 \ubc1c\uc0dd\ud558\ub294 \uace0\ube44\uc6a9 \uce58\ub8cc\ub97c \ud53c\ud560 \uc218 \uc788\uac8c \ud558\uc5ec, \uc644\ud654 \uce58\ub8cc\uc5d0\uc11c \uc644\uce58\ub85c \uac00\uce58\ub97c \uc804\ud658\uc2dc\ud0b5\ub2c8\ub2e4. \ubcf4\uc870 \uc694\ubc95 \uc784\uc0c1 \uc2dc\ud5d8\uc5d0\uc11c \uc7a5\uae30 \uc0dd\uc874\uc728\uc744 \uc785\uc99d\ud558\ub294 \uc81c\uc870\uc5c5\uccb4\ub294 \uc0c1\ub2f9\ud558\uace0 \uc9c0\uc18d\uc801\uc778 \ub9e4\ucd9c \ud750\ub984\uc744 \ud655\ubcf4\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 3.4. \ud22c\uc5ec \uacbd\ub85c\ubcc4 (By Route of Administration)<\/p>\n<p>\uc815\ub9e5 \uc8fc\uc0ac \uc81c\ud488\uc740 2025\ub144 \ub9e4\ucd9c\uc758 49.05%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \ud53c\ud558 \uc8fc\uc0ac \uc81c\ud615\uc740 \uc7ac\ud615\uc131(reformulation)\uc744 \ud1b5\ud574 \uc9c4\ub8cc\uc2e4 \uccb4\ub958 \uc2dc\uac04\uc744 \uc904\uc774\uace0 \uc790\uac00 \ud22c\uc5ec\ub97c \uc6a9\uc774\ud558\uac8c \ud568\uc5d0 \ub530\ub77c 11.35%\uc758 CAGR\ub85c \ud655\uc7a5\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uacbd\uad6c \ud45c\uc801 \uce58\ub8cc\uc81c \ub610\ud55c \uc720\ub9ac\ud55c \uc57d\ub3d9\ud559\uc801 \ud2b9\uc131\uacfc \ud658\uc790 \uc218\uc6a9\ub3c4\ub97c \ubc18\uc601\ud558\uc5ec \ubc1c\uc804\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. COVID-19 \ud32c\ub370\ubbf9\uc740 \uc6d0\uaca9 \uc9c4\ub8cc \ubaa8\ub378\uc744 \ubcf4\ud3b8\ud654\ud558\uc5ec \ud3b8\ub9ac\ud55c \ud22c\uc5ec \uacbd\ub85c\uc5d0 \ub300\ud55c \uc218\uc694\ub97c \uac15\ud654\ud588\uc2b5\ub2c8\ub2e4. \uc9c0\ubd88\uc790\ub4e4\uc740 \uc7ac\ud0dd \uce58\ub8cc \uc635\uc158\uc744 \ube44\uc6a9 \uc808\uac10\uc73c\ub85c \uac04\uc8fc\ud558\uba70, \ud658\uc790\ub4e4\uc740 \ubcd1\uc6d0 \ubc29\ubb38 \ud69f\uc218\ub97c \uc904\uc774\ub294 \uac83\uc744 \uc120\ud638\ud569\ub2c8\ub2e4. \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc815\ub9e5 \uc8fc\uc0ac \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\ub97c \ud6a8\ub2a5 \uc190\uc2e4 \uc5c6\uc774 \ud53c\ud558 \uc8fc\uc0ac \ub610\ub294 \uacbd\uad6c \uc81c\ud615\uc73c\ub85c \uc804\ud658\ud560 \uc218 \uc788\ub294 \uae30\uc5c5\uc5d0 \ubcf4\uc0c1\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p> 3.5. \uc720\ud1b5 \ucc44\ub110\ubcc4 (By Distribution Channel)<\/p>\n<p>\ubcd1\uc6d0 \uc57d\uad6d\uc740 2025\ub144 \ub9e4\ucd9c\uc758 64.60%\ub97c \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc804\uc790\uc0c1\uac70\ub798\ub294 \uc870\uc81c\uc640 \ub514\uc9c0\ud138 \ubcf5\uc57d \uc21c\uc751\ub3c4 \uc9c0\uc6d0\uc744 \uacb0\ud569\ud55c \uc804\ubb38 \ud50c\ub7ab\ud3fc\uc5d0 \uc758\ud574 \ucd09\ub9e4\ub418\uc5b4 \uc5f0\uac04 12.05% \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc18c\ub9e4 \ubc0f \uc804\ubb38 \uc57d\uad6d\uc740 \uacbd\uad6c \uc694\ubc95\uc5d0 \ub300\ud55c \uad50\uc721 \uaca9\ucc28\ub97c \ud574\uc18c\ud558\uba70, \ud658\uc790 \uc9c1\uc811 \ubc30\uc1a1\uc740 \uc81c\uc870\uc5c5\uccb4\uc640 \ud658\uc790 \uac04\uc758 \uc5f0\uacb0\uc744 \uac15\ud654\ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ucc44\ub110 \ubcc0\ud654\ub294 \ub370\uc774\ud130 \uc218\uc9d1\uc744 \uac00\uc18d\ud654\ud558\uc5ec \uac00\uce58 \uae30\ubc18 \uacc4\uc57d\uc5d0 \uc911\uc694\ud55c \uc2e4\uc81c \uc99d\uac70(real-world evidence)\ub97c \uc0dd\uc131\ud569\ub2c8\ub2e4. \uc720\ud1b5\uc5d0 \ub514\uc9c0\ud138 \uac74\uac15 \uc11c\ube44\uc2a4\ub97c \ud1b5\ud569\ud558\ub294 \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc740 \uacbd\uc7c1 \uc6b0\uc704\ub97c \ud655\ubcf4\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p># 4. \uc9c0\uc5ed\ubcc4 \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \ub9e4\ucd9c\uc758 38.05%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc774\ub294 \uc2e0\uc57d\uc758 \ube60\ub978 \ucc44\ud0dd\uacfc \uad11\ubc94\uc704\ud55c \ubcf4\ud5d8 \uc801\uc6a9\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. FDA\uc758 Project Optimus\uc640 \uac19\uc740 \uc774\ub2c8\uc154\ud2f0\ube0c\ub294 \uc804 \uc138\uacc4\uc801\uc778 \uc6a9\ub7c9 \ud45c\uc900\uc5d0 \uc601\ud5a5\uc744 \ubbf8\uce69\ub2c8\ub2e4. \ud2b8\ub77c\uc2a4\ud22c\uc8fc\ub9d9 \ud6c4\uc18d \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 \uce68\ud22c\ub294 \uc9c0\ucd9c \uc99d\uac00\ub97c \uc5b5\uc81c\ud558\uc9c0\ub9cc \uc811\uadfc\uc131\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 11.85%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub418\uba70, \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uc8fc\uc694 \ud655\uc7a5 \ub3d9\ub825\uc774 \ub420 \uac83\uc785\ub2c8\ub2e4. \uc758\ub8cc \uc2dc\uc2a4\ud15c \ud22c\uc790, \uad11\ubc94\uc704\ud55c \uac80\uc9c4, \uac00\ucc98\ubd84 \uc18c\ub4dd \uc99d\uac00\ub294 \uc911\uad6d\uacfc \uc778\ub3c4\uc5d0\uc11c \ud310\ub9e4\ub7c9\uc744 \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4. \uc77c\ubcf8\uc740 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \ucc44\ud0dd\uc744 \ucd09\uc9c4\ud558\ub294 \ud6a8\uacfc\uc801\uc778 \uc778\uc13c\ud2f0\ube0c\ub97c \ubcf4\uc5ec\uc8fc\uba70, \ud55c\uad6d\uacfc \ud638\uc8fc\ub294 \ud601\uc2e0 \ud14c\uc2a4\ud2b8\ubca0\ub4dc \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: \ub2e4\uc911 \uc9c0\ubd88\uc790 \ud658\uacbd\uc740 \uac00\uaca9 \ucc45\uc815\uc744 \uc644\ud654\ud558\uc9c0\ub9cc \uc5ec\uc804\ud788 \uc0c1\ub2f9\ud55c \uc2dc\uc7a5 \uaddc\ubaa8\ub97c \uc720\uc9c0\ud569\ub2c8\ub2e4. \ubcf4\uac74 \uae30\uc220 \ud3c9\uac00(HTA) \uc694\uad6c \uc0ac\ud56d\uc740 \uc7a5\uae30\uc801\uc778 \uacb0\uacfc \ub370\uc774\ud130\uc758 \uc911\uc694\uc131\uc744 \ub192\uc785\ub2c8\ub2e4. \ub3d9\uc720\ub7fd\uc758 \ud604\ub300\ud654\ub294 \uc810\uc9c4\uc801\uc778 \uc0c1\uc2b9 \uc5ec\ub825\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74: \uc811\uadfc\uc131\uc774 \ub4a4\ucc98\uc9c0\uc9c0\ub9cc, \uc0ac\uc6b0\ub514\uc544\ub77c\ube44\uc544\uc758 \uad6d\uac00 \uc554 \uacc4\ud68d\uc740 \uac00\uc6a9\uc131 \uac1c\uc120\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.<br \/>\n*   \ub0a8\ubbf8: \ud63c\ud569\ub41c \uc131\uacfc\ub97c \ubcf4\uc774\uba70, \ube0c\ub77c\uc9c8\uc774 \ucc44\ud0dd\uc744 \uc8fc\ub3c4\ud558\ub294 \ubc18\uba74, \uc18c\uaddc\ubaa8 \uacbd\uc81c\uad6d\ub4e4\uc740 \uacbd\uc81c\uc131 \ubb38\uc81c\ub85c \uc5b4\ub824\uc6c0\uc744 \uacaa\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 5. \uacbd\uc7c1 \ud658\uacbd \ubc0f \uc8fc\uc694 \uae30\uc5c5<\/p>\n<p>\uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc785\ub2c8\ub2e4. \ub178\ubc14\ud2f0\uc2a4(Novartis AG)\ub294 \ub9ac\ubcf4\uc2dc\ud074\ub9bd\uc758 \ubcf4\uc870 \uc694\ubc95 \uc2b9\uc778\uc744 \ud65c\uc6a9\ud558\uc5ec HR-\uc591\uc131 \uc9c8\ud658 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ubc29\uc5b4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74(AstraZeneca)\uc640 \ub2e4\uc774\uc774\ucc0c\uc0b0\ucfc4(Daiichi Sankyo)\ub294 \ud2b8\ub77c\uc2a4\ud22c\uc8fc\ub9d9 \ub370\ub8e9\uc2a4\ud14c\uce78\uc758 \uc801\uc751\uc99d\uc744 \uacc4\uc18d \ud655\uc7a5\ud558\uba70 \ub192\uc740 \uc784\uc0c1 \uae30\uc900\uc744 \uc124\uc815\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>ADC \uac1c\ubc1c\uc740 \uc804\ub7b5\uc801 \ub85c\ub4dc\ub9f5\uc744 \uc9c0\ubc30\ud558\uba70, \uc0ac\ub178\ud53c-\uc624\ub77c\ub178 \uba54\ub4dc \ubc0f \uc77c\ub77c\uc774 \ub9b4\ub9ac-\ub77c\ub514\uc624\ub124\ud2f1\uc2a4\uc640 \uac19\uc740 \uc81c\ud734\ub97c \ucd09\uc9c4\ud569\ub2c8\ub2e4. CLAIRITY BREAST\uc640 \uac19\uc740 AI \uae30\ubc18 \ud50c\ub7ab\ud3fc\uc740 \uc9c4\ub2e8 \uae30\uc220\uc774 \uce58\ub8cc \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c \uc5b4\ub5bb\uac8c \uac15\ud654\ud558\ub294\uc9c0 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uc0bc\uc131\ubc14\uc774\uc624\uc5d0\ud53c\uc2a4(Samsung Bioepis)\uc640 \uc140\ud2b8\ub9ac\uc628(Celltrion)\uc744 \ud3ec\ud568\ud55c \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uae30\uc5c5\ub4e4\uc740 \uc9c0\ubd88\uc790\uc758 \uc608\uc0b0\uc744 \ucc28\uc138\ub300 \uc57d\ubb3c\uc5d0 \uc0ac\uc6a9\ud560 \uc218 \uc788\ub3c4\ub85d \ud558\ub294 \uac00\uaca9-\ubb3c\ub7c9 \uc804\ub7b5\uc744 \ucd94\uad6c\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc138\ud3ec\ub3c5\uc131 \ud398\uc774\ub85c\ub4dc(cytotoxic payload)\uc758 \uc81c\uc870 \ud655\uc7a5\uc131\uc740 \uacbd\uc7c1 \ucc28\ubcc4\ud654 \uc694\uc18c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc804\uc6a9 \uc2dc\uc124\uc5d0 \ud22c\uc790\ud558\ub294 \uae30\uc5c5\uc740 \uacf5\uae09 \uc704\ud5d8\uc744 \uc644\ud654\ud558\uace0 \ucd9c\uc2dc \uc900\ube44\ub97c \ubcf4\uc7a5\ud569\ub2c8\ub2e4. \ud55c\ud3b8, \ub514\uc9c0\ud138 \ud5ec\uc2a4 \ud30c\ud2b8\ub108\uc2ed\uc740 \uae30\uc5c5\uc774 \uc57d\ubb3c \uadf8 \uc774\uc0c1\uc73c\ub85c \ud655\uc7a5\ud558\uc5ec \ubcf5\uc57d \uc21c\uc751\ub3c4\ub97c \uac1c\uc120\ud558\uace0 \ubcf4\ud5d8 \uc0c1\ud658 \ud611\uc0c1\uc744 \uc704\ud55c \uc2e4\ud589 \uac00\ub2a5\ud55c \ub370\uc774\ud130\ub97c \uc0dd\uc131\ud558\ub294 \ub370 \ub3c4\uc6c0\uc744 \uc90d\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec \uae30\uc5c5:<br \/>\n*   Novartis AG<br \/>\n*   Merck Co &#038; Inc.<br \/>\n*   Fresenius Kabi<br \/>\n*   Pfizer Inc.<br \/>\n*   Eli Lilly &#038; Co.<\/p>\n<p># 6. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 5\uc6d4: \uba38\ud06c(Merck)\ub294 KEYTRUDA\uc640 Trodelvy \ubcd1\uc6a9 \uc694\ubc95\uc774 1\ucc28 PD-L1+ \uc804\uc774\uc131 \uc0bc\uc911 \uc74c\uc131 \uc720\ubc29\uc554(TNBC)\uc5d0\uc11c KEYTRUDA\uc640 \ud654\ud559 \uc694\ubc95 \ubcd1\uc6a9 \ub300\ube44 \uc9c8\ubcd1 \uc9c4\ud589 \uc704\ud5d8\uc744 35% \uac10\uc18c\uc2dc\ucf30\ub2e4\uace0 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 1\uc6d4: FDA\ub294 \ud2b8\ub77c\uc2a4\ud22c\uc8fc\ub9d9 \ub370\ub8e9\uc2a4\ud14c\uce78\uc744 HER2-low \ubc0f ultralow \uc9c8\ud658\uc5d0 \ub300\ud574 \uc2b9\uc778\ud558\uc5ec \uce58\ub8cc \uae30\ubc18\uc744 \ud655\ub300\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud558\uba70, \uc2dc\uc7a5 \uc815\uc758, \uc131\uc7a5 \ub3d9\uc778 \ubc0f \uc81c\uc57d \uc694\uc778, \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21, \uacbd\uc7c1 \ud658\uacbd, \uadf8\ub9ac\uace0 \ubbf8\ub798 \uc804\ub9dd\uc744 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>1. \uc2dc\uc7a5 \uc815\uc758 \ubc0f \ubc94\uc704<br \/>\n\uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc720\ubc29\uc554\uc758 \uc644\uce58 \ub610\ub294 \uc644\ud654 \uad00\ub9ac\ub97c \uc704\ud574 \ud22c\uc5ec\ub418\ub294 \ubaa8\ub4e0 \ucc98\ubc29 \uc758\uc57d\ud488, \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADC), \uc138\ud3ec \uae30\ubc18 \uba74\uc5ed\uce58\ub8cc\uc81c \ubc0f \ubcf4\uc870 \ud638\ub974\ubaac\uc81c\ub97c \ud3ec\ud568\ud569\ub2c8\ub2e4. \uc774\ub294 \ubcf4\uc870 \uc694\ubc95, \uc120\ud589 \ubcf4\uc870 \uc694\ubc95 \ubc0f \uc804\uc774\uc131 \ud658\uacbd\uc5d0\uc11c\uc758 \uce58\ub8cc\ub97c \uc544\uc6b0\ub974\uba70, \ubc29\uc0ac\uc120 \uc7a5\ube44 \ubc0f \uc218\uc220 \uc808\ucc28\ub294 \uc218\uc775 \uc0b0\uc815\uc5d0\uc11c \uc81c\uc678\ub429\ub2c8\ub2e4. \ubd84\uc11d \ubc94\uc704\ub294 17\uac1c\uad6d\uc5d0\uc11c \uc81c\uc870\uc0ac \ub9e4\ucd9c\uc744 \ucc3d\ucd9c\ud558\ub294 \ube0c\ub79c\ub4dc \ubc0f \uc2b9\uc778\ub41c \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc81c\ud488\uc744 \ud3ec\ud568\ud558\uba70, \uc77c\ubc18\uc758\uc57d\ud488(OTC), \uc9c4\ub2e8 \uc601\uc0c1, \uc720\uc804\uc790 \uac80\uc0ac \ud0a4\ud2b8 \ubc0f \ube44\uc885\uc591\ud559\uc801 \uc624\ud504\ub77c\ubca8 \uc57d\ubb3c \ud310\ub9e4\ub294 \uc81c\uc678\ub429\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21<br \/>\n\uc720\ubc29\uc554 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 2026\ub144 352.3\uc5b5 \ub2ec\ub7ec\ub97c \uae30\ub85d\ud588\uc73c\uba70, 2031\ub144\uc5d0\ub294 495.9\uc5b5 \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub294 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc0c1\ub2f9\ud55c \uc131\uc7a5\uc138\ub97c \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uce58\ub8cc\ubc95\ubcc4\ub85c\ub294 \ud45c\uc801 \uce58\ub8cc\uc81c\uac00 2025\ub144 \ub9e4\ucd9c\uc758 62.45%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 11.85%\uc758 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uce21\ub418\ub294\ub370, \uc774\ub294 \ud5ec\uc2a4\ucf00\uc5b4 \uc778\ud504\ub77c \ud22c\uc790 \ud655\ub300, \uac80\uc9c4 \uc811\uadfc\uc131 \uc99d\ub300 \ubc0f \uc18c\ub4dd \uc218\uc900 \ud5a5\uc0c1\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. \ud2b9\ud788 \uc0bc\uc911 \uc74c\uc131 \uc720\ubc29\uc554(TNBC) \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 TROP2 \ud45c\uc801 ADC(\uc608: \uc0ac\uc2dc\ud22c\uc8fc\ub9d9 \uace0\ube44\ud14c\uce78)\uc758 \ubc1c\uc804\uc73c\ub85c 12.08%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \ubcf4\uc774\uba70, \ud53c\ud558 \uc8fc\uc0ac \uc81c\ud615\uc740 \ud658\uc790 \ud3b8\uc758\uc131 \ubc0f \uc8fc\uc785 \ube44\uc6a9 \uc808\uac10\uc5d0 \ub300\ud55c \uad00\uc2ec \uc99d\uac00\ub85c 11.35%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \ub3d9\uc778<br \/>\n\uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\ub4e4\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ubc29\uc554\uc758 \ub192\uc740 \ubc1c\ubcd1\ub960 \ubc0f \uc720\ubcd1\ub960: \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc720\ubc29\uc554 \ud658\uc790 \uc218\uac00 \uc9c0\uc18d\uc801\uc73c\ub85c \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   R&#038;D \uc9c0\ucd9c \ubc0f \uc885\uc591\ud559 \ubd84\uc57c \uac70\ub798 \uc99d\uac00: \uc81c\uc57d\uc0ac\ub4e4\uc758 \uc5f0\uad6c \uac1c\ubc1c \ud22c\uc790 \ud655\ub300\uc640 \ud65c\ubc1c\ud55c \uc778\uc218\ud569\ubcd1 \ubc0f \ud30c\ud2b8\ub108\uc2ed\uc774 \uc2e0\uc57d \uac1c\ubc1c\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4.<br \/>\n*   HER2 \/ CDK4-6 \ud45c\uc801 \uce58\ub8cc\uc81c\uc758 \ube60\ub978 \ucc44\ud0dd: \ud601\uc2e0\uc801\uc778 \ud45c\uc801 \uce58\ub8cc\uc81c\ub4e4\uc774 \uc784\uc0c1 \ud604\uc7a5\uc5d0\uc11c \ube60\ub974\uac8c \ub3c4\uc785\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc2e0\ud765 \uacbd\uc81c\uad6d\uc758 \uac80\uc9c4 \uc811\uadfc\uc131 \ud655\ub300: \uc870\uae30 \uc9c4\ub2e8 \ubc0f \uce58\ub8cc \uae30\ud68c\uac00 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc1c\uacac\uc744 \ud1b5\ud55c \ud30c\uc774\ud504\ub77c\uc778 \uac00\uc18d\ud654: \uc778\uacf5\uc9c0\ub2a5 \uae30\uc220\uc774 \uc2e0\uc57d \uac1c\ubc1c \uacfc\uc815\uc744 \ud6a8\uc728\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778<br \/>\n\uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\ub4e4 \ub610\ud55c \uc874\uc7ac\ud569\ub2c8\ub2e4.<br \/>\n*   \ubd80\uc791\uc6a9 \ubc0f \ub3c5\uc131 \uad00\ub9ac \ube44\uc6a9: \uce58\ub8cc \uacfc\uc815\uc5d0\uc11c \ubc1c\uc0dd\ud558\ub294 \ubd80\uc791\uc6a9 \uad00\ub9ac \ubc0f \uad00\ub828 \ube44\uc6a9\uc774 \ubd80\ub2f4\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<br \/>\n*   \uc5c4\uaca9\ud55c \ub2e4\uc9c0\uc5ed \uaddc\uc81c \uc2b9\uc778 \uc808\ucc28: \uc5ec\ub7ec \uad6d\uac00\uc758 \ubcf5\uc7a1\ud558\uace0 \uae34 \uaddc\uc81c \uc2b9\uc778 \uacfc\uc815\uc774 \uc2e0\uc57d \ucd9c\uc2dc\ub97c \uc9c0\uc5f0\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   \uace0\ud6a8\ub2a5 ADC \ud398\uc774\ub85c\ub4dc \uc81c\uc870\uc758 \ud76c\uc18c\uc131: \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADC)\uc758 \ud575\uc2ec \uad6c\uc131 \uc694\uc18c\uc778 \uace0\ud6a8\ub2a5 \ud398\uc774\ub85c\ub4dc \uc81c\uc870 \uc5ed\ub7c9\uc774 \uc81c\ud55c\uc801\uc785\ub2c8\ub2e4.<\/p>\n<p>5. \uc2dc\uc7a5 \uc138\ubd84\ud654<br \/>\n\uc2dc\uc7a5\uc740 \ub2e4\uc591\ud55c \uae30\uc900\uc5d0 \ub530\ub77c \uc138\ubd84\ud654\ub418\uc5b4 \ubd84\uc11d\ub429\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc\ubc95\ubcc4: \ubc29\uc0ac\uc120 \uce58\ub8cc, \ud638\ub974\ubaac \uce58\ub8cc, \ud654\ud559\uc694\ubc95, \ud45c\uc801 \uce58\ub8cc, \uba74\uc5ed\uc694\ubc95.<br \/>\n*   \ubd84\uc790 \uc544\ud615\ubcc4: HR+ \/ HER2-, HER2+, \uc0bc\uc911 \uc74c\uc131(TNBC), \uc0ac\uc911 \uc74c\uc131(QNBC).<br \/>\n*   \uc9c8\ubcd1 \ub2e8\uacc4\ubcc4: \ucd08\uae30 \/ \ubcf4\uc870 \uc694\ubc95, \uc804\uc774\uc131 \/ \uc9c4\ud589\uc131.<br \/>\n*   \ud22c\uc5ec \uacbd\ub85c\ubcc4: \uc815\ub9e5 \uc8fc\uc0ac, \ud53c\ud558 \uc8fc\uc0ac, \uacbd\uad6c.<br \/>\n*   \uc720\ud1b5 \ucc44\ub110\ubcc4: \ubcd1\uc6d0 \uc57d\uad6d, \uc18c\ub9e4 \ubc0f \uc804\ubb38 \uc57d\uad6d, \uc804\uc790\uc0c1\uac70\ub798.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54), \uc720\ub7fd(\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778 \ub4f1), \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591(\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud55c\uad6d, \ud638\uc8fc \ub4f1), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8.<\/p>\n<p>6. \uacbd\uc7c1 \ud658\uacbd<br \/>\n\uc2dc\uc7a5\uc740 Roche Holding AG, Novartis AG, Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, Bristol-Myers Squibb, Merck &#038; Co., Johnson &#038; Johnson (Janssen), GSK plc, Eisai Co. Ltd \ub4f1 20\uac1c \uc8fc\uc694 \uae00\ub85c\ubc8c \uae30\uc5c5\ub4e4\uc774 \uacbd\uc7c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubcf4\uace0\uc11c\ub294 \uc774\ub4e4 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 \uac01 \uae30\uc5c5\uc758 \uae00\ub85c\ubc8c \ubc0f \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \uc0ac\uc5c5 \ubd80\ubb38, \uc7ac\ubb34, \uc778\ub825, \uc8fc\uc694 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ub3d9\ud5a5 \ub4f1\uc744 \ud3ec\ud568\ud55c \uc0c1\uc138 \ud504\ub85c\ud544\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>7. \uc5f0\uad6c \ubc29\ubc95\ub860 \ubc0f \uc2e0\ub8b0\uc131<br \/>\n\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc758\ub8cc \uc885\uc591 \uc804\ubb38\uc758, \ubcd1\uc6d0 \uc57d\uc0ac, \uc9c0\ubd88\uc790 \uc790\ubb38\uac00 \ub4f1\uacfc\uc758 1\ucc28 \uc778\ud130\ubdf0\uc640 \uc138\uacc4\ubcf4\uac74\uae30\uad6c(WHO), GLOBOCAN, \ubbf8\uad6d SEER \ud504\ub85c\uadf8\ub7a8, Eurostat, \uac01\uad6d \ubcf4\uac74\ubd80 \ub4f1 \uacf5\uacf5 \ub370\uc774\ud130 \ubc0f US FDA, \uc720\ub7fd\uc758\uc57d\ud488\uccad(EMA)\uc758 \uaddc\uc81c \uc870\uce58 \uae30\ub85d, \uae30\uc5c5 \ubcf4\uace0\uc11c, \ud559\uc220\uc9c0, \uad6c\ub3c5 \ub370\uc774\ud130\ubca0\uc774\uc2a4 \ub4f1\uc744 \ud65c\uc6a9\ud55c 2\ucc28 \uc870\uc0ac\ub97c \ud1b5\ud574 \ub370\uc774\ud130\ub97c \uc218\uc9d1\ud558\uace0 \uac80\uc99d\ud569\ub2c8\ub2e4. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc608\uce21\uc740 \ubc1c\ubcd1\ub960, \ubcd1\uae30 \ubd84\ud3ec, \uce58\ub8cc \uc801\uaca9\uc131, \uce58\ub8cc \ub77c\uc778 \uce68\ud22c\uc728 \ub4f1\uc744 \uae30\ubc18\uc73c\ub85c \ud55c \ud558\ud5a5\uc2dd \ubaa8\ub378\uacfc \uc120\ub3c4 \ubc14\uc774\uc624\uc758\uc57d\ud488 \uacf5\uae09\uc5c5\uccb4 \ub864\uc5c5 \ubc0f \ubcd1\uc6d0 \uccad\uad6c\uc11c \ub370\uc774\ud130 \uc0d8\ud50c\ub9c1\uc744 \ud1b5\ud55c \uc0c1\ud5a5\uc2dd \uac80\uc99d\uc744 \uacb0\ud569\ud558\uc5ec \uc0b0\ucd9c\ub429\ub2c8\ub2e4. Mordor Intelligence\uc758 \ubd84\uc11d\uc740 \uba85\ud655\ud55c \ubc94\uc704 \uc124\uc815, \ud658\uc790 \ud750\ub984 \ub17c\ub9ac, \uc5f0\uac04 \ub370\uc774\ud130 \uc5c5\ub370\uc774\ud2b8, \ud1b5\uc81c\ub41c \ud3c9\uade0 \ud310\ub9e4 \uac00\uaca9(ASP) \ub9e4\ud551\uc744 \ud1b5\ud574 \uc2dc\uc7a5 \ucd94\uc815\uce58\uc758 \uc2e0\ub8b0\uc131\uc744 \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>8. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<br \/>\n\ubcf4\uace0\uc11c\ub294 \ubbf8\ucda9\uc871 \uc218\uc694 \ubc0f \uc7a0\uc7ac\uc801 \uc2dc\uc7a5 \uae30\ud68c\ub97c \ud3c9\uac00\ud558\uc5ec \ud5a5\ud6c4 \uc2dc\uc7a5\uc758 \uc131\uc7a5 \uac00\ub2a5\uc131\uacfc \uc804\ub7b5\uc801 \ubc29\ud5a5\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-46981","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/46981"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=46981"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/46981\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=46981"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=46981"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=46981"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}